These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26379432)

  • 1. Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease.
    Kim J; Yoon HI; Oh YM; Lim SY; Lee JH; Kim TH; Lee SY; Lee JH; Lee SD; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1819-27. PubMed ID: 26379432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
    Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP;
    Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study.
    Prats E; Tejero E; Pardo P; Gavilán A; Galera R; Donado JR; Racionero MÁ; Casitas R; Zapatero A; García-Río F
    PLoS One; 2015; 10(10):e0140855. PubMed ID: 26489023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017.
    Menezes AM; Wehrmeister FC; Perez-Padilla R; Viana KP; Soares C; Müllerova H; Valdivia G; Jardim JR; Montes de Oca M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1491-1501. PubMed ID: 28553101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease.
    Oda N; Miyahara N; Ichikawa H; Tanimoto Y; Kajimoto K; Sakugawa M; Kawai H; Taniguchi A; Morichika D; Tanimoto M; Kanehiro A; Kiura K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1119-1124. PubMed ID: 28435245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.
    Anzueto A; Wise R; Calverley P; Dusser D; Tang W; Metzdorf N; Dahl R
    Respir Res; 2015 Sep; 16(1):107. PubMed ID: 26369563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pulmonary rehabilitation on lung function in chronic obstructive pulmonary disease: the FIRST study.
    Incorvaia C; Russo A; Foresi A; Berra D; Elia R; Passalacqua G; Riario-Sforza GG; Ridolo E
    Eur J Phys Rehabil Med; 2014 Aug; 50(4):419-26. PubMed ID: 24691247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease.
    Bhatt SP; Soler X; Wang X; Murray S; Anzueto AR; Beaty TH; Boriek AM; Casaburi R; Criner GJ; Diaz AA; Dransfield MT; Curran-Everett D; Galbán CJ; Hoffman EA; Hogg JC; Kazerooni EA; Kim V; Kinney GL; Lagstein A; Lynch DA; Make BJ; Martinez FJ; Ramsdell JW; Reddy R; Ross BD; Rossiter HB; Steiner RM; Strand MJ; van Beek EJ; Wan ES; Washko GR; Wells JM; Wendt CH; Wise RA; Silverman EK; Crapo JD; Bowler RP; Han MK;
    Am J Respir Crit Care Med; 2016 Jul; 194(2):178-84. PubMed ID: 26808615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease progression in young patients with COPD: rethinking the Fletcher and Peto model.
    Sanchez-Salcedo P; Divo M; Casanova C; Pinto-Plata V; de-Torres JP; Cote C; Cabrera C; Zagaceta J; Rodriguez-Roisin R; Zulueta JJ; Marin JM; Celli B
    Eur Respir J; 2014 Aug; 44(2):324-31. PubMed ID: 24696115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.
    Nishimura M; Makita H; Nagai K; Konno S; Nasuhara Y; Hasegawa M; Shimizu K; Betsuyaku T; Ito YM; Fuke S; Igarashi T; Akiyama Y; Ogura S;
    Am J Respir Crit Care Med; 2012 Jan; 185(1):44-52. PubMed ID: 22016444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung function decline in COPD.
    Tantucci C; Modina D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():95-9. PubMed ID: 22371650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related annual decline of lung function in patients with COPD.
    Kim SJ; Lee J; Park YS; Lee CH; Yoon HI; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():51-60. PubMed ID: 26766907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of direct substitution of arm span length for current standing height in elderly COPD.
    Pothirat C; Chaiwong W; Phetsuk N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1173-8. PubMed ID: 26150709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis.
    Chen W; Sadatsafavi M; FitzGerald JM; Lynd LD; Sin DD
    Respir Res; 2021 Feb; 22(1):59. PubMed ID: 33602241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new staging strategy for chronic obstructive pulmonary disease.
    Miller MR; Pedersen OF; Dirksen A
    Int J Chron Obstruct Pulmon Dis; 2007; 2(4):657-63. PubMed ID: 18268941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data.
    Lee HY; Choi SM; Lee J; Park YS; Lee CH; Kim DK; Lee SM; Yoon HI; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2185-92. PubMed ID: 26508848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.